At Glooko, we believe being named a leader in CB Insights’ Diabetes Digital Therapeutics For Healthcare Payers — Execution & Market Strength Positioning (ESP) Vendor Matrix validates what our customers have been saying about our commitment to providing innovative digital health tools for chronic conditions like diabetes. Glooko was among the select companies that CB… Continue reading Glooko Named a Leader by Independent Research Firm in Diabetes Digital Therapeutics for Healthcare Payers